Empowering Caregivers Conference 2025
November 19, 2025 Illuminate Event Venue 5100 N Nob Hill Road, Sunrise, FL 33351 Registration – 8:30 AM – 9:00 AM I Event Hours – 9:00 AM – 3:30 PM Join […]
Alzheimer’s disease
Dr. Jeffrey Gelblum Talks about Proton Pump Inhibitors and Your Risk of Dementia
Dr. Jeffrey Gelblum, Senior Neurologist at First Choice Neurology educates patients about the risk of dementia and Alzheimer’s disease. Dr. Gelblum offers bi-weekly Lunch and Learn talks on Facebook LIVE
Dr. Jeffrey Gelblum Talks about Proton Pump Inhibitors and Your Risk of Dementia Read More »
FDA Panel Recommends Full Approval for New Alzheimer’s Drug in June, Alzheimer’s & Brain Awareness Month
June is an important month for raising awareness about Alzheimer’s disease and promoting brain health. This year, Alzheimer’s & Brain Awareness Month brings exceptional news for those affected by this
Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline
A late-stage clinical trial was conducted by Biogen and Eisai and the new Alzheimer’s drug they are developing for Alzheimer’s disease slowed the rate of cognitive decline. New Alzheimer’s Drug
Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline Read More »
First Florida Patient to Receive Biogen Aducanumab Infusion
Jeff Gelblum, MD, a board-certified neurologist with First Choice Neurology, the nation’s largest neurology practice, is scheduled to treat the first patient in Florida with Biogen’s Aducanumab (Aduhelm), a monthly
First Florida Patient to Receive Biogen Aducanumab Infusion Read More »
Lumbar Puncture for Cerebrospinal Fluid is a Vital Tool to Assess Amyloid Build Up in Alzheimer’s
In recent years, research has shown that tests of cerebrospinal fluid (CSF) can be a valuable tool for the detection of hallmark proteins that are involved in diseases that cause
Medicare Sees a Growing Demand for Cognitive Assessment with Patients Suffering from Memory Disorders
Dr. Jeff Gelblum, a board-certified Neurologist with First Choice Neurology, makes great use of the cognitive assessment in his daily practice. Gelblum states, “this activity enables me to determine the
FDA Approves Promising Alzheimer’s Treatment
Leading Florida Neurologists Available to Speak about Biogen Aducanumab Treatment Alzheimer’s patients and their families, as well as the medical community, are celebrating today’s decision by the FDA. They approved
Alzheimer’s Patients and Holiday Gatherings
The holidays can be a stressful time, especially for families of a loved one diagnosed with Alzheimer’s disease. When a family member has dementia or Alzheimer’s disease, the family dynamic